Search results
Results from the WOW.Com Content Network
ABC excluded the entire PFS Program from its standard regulatory audit and pedigree compliance programs. [32] [33] AmerisourceBergen's stock price reportedly plummeted after they were among other drug distributors who offered $10 billion to settle their portion of the national opioids lawsuit. [34] [35] States countered with $45 billion. [36]
AmerisourceBergen (ABC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment.
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AmerisourceBergen (ABC) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 ...
South Africa. Title. Chairman, president and CEO, AmerisourceBergen. Predecessor. R. David Yost. Successor. incumbent. Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen. [2][3][4][5]